Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN519156 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-serglycin (SRGN) (AA 1-158), (full length) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-158, full length
- Isotype
- IgG
- Antibody clone number
- 1D8
- Vial size
- 100 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages.
Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis.
Gasimli L, Hickey AM, Yang B, Li G, dela Rosa M, Nairn AV, Kulik MJ, Dordick JS, Moremen KW, Dalton S, Linhardt RJ
Biochimica et biophysica acta 2014 Jun;1840(6):1993-2003
Biochimica et biophysica acta 2014 Jun;1840(6):1993-2003
Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
Reine TM, Vuong TT, Jenssen TG, Kolset SO
Biochimica et biophysica acta 2014 Aug;1840(8):2498-505
Biochimica et biophysica acta 2014 Aug;1840(8):2498-505
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis.
Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A, Peng LX, Lu WH, Zhang Z, Petillo D, Qin L, Bao YN, Zheng FJ, Chia CS, Iyer NG, Kang TB, Zeng YX, Soo KC, Trent JM, Teh BT, Qian CN
Cancer research 2011 Apr 15;71(8):3162-72
Cancer research 2011 Apr 15;71(8):3162-72
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA